CNBC Daily Open: A year-end rally is still on every trader's wishlist

U.S. equities rallied Tuesday led by technology names while Bitcoin recovered some losses, as investors price an 89.2% probability of a 25bp Fed cut at the Dec. 10 meeting per the CME FedWatch Tool. Market focus is shifting to stronger-than-expected Q4 and 2026 earnings outlooks even as digital-asset treasury (DAT) firms face scrutiny after crypto price declines (Bitcoin down ~20% recently) and tariffs raise concerns about potential U.S. job cuts amid ISM employment slipping to 44%. European and corporate-specific moves include Bayer shares rising after U.S. litigation was curbed, and tech momentum was bolstered by Mistral’s new AI models following its €1.7bn funding round; meanwhile China’s property downturn deepened with top-100 developer sales down 36% YoY and Morgan Stanley estimating a 42% YoY sales decline for 25 major developers in November.

Analysis

Market structure is bifurcating: AI hardware and semicap suppliers (NVDA, ASML) are clear winners as investor risk appetite and Mistral-style model releases point to continued GPU/equipment demand; expect 12–30% revenue leverage for NVDA/ASML over 12–18 months if enterprise AI capex continues. Losers include DAT-heavy public vehicles, crypto-levered names and cyclical domestic-exposed firms (tariff-sensitive manufacturing, US small-cap employment weak) as crypto drawdowns create NAV discounts and tariffs/real-estate weakness sap demand.

Tail risks center on policy and contagion: a surprise “no cut” on Dec 10 (market has priced a 89% chance of a 25bp cut) could trigger a -3% to -6% equity gap in days; prolonged China property stress or a crypto regulatory clamp could force forced liquidations among DAT players. Time horizons split: immediate (days around FOMC), short-term (weeks–months for earnings guidance and BTC price path), long-term (quarters for AI capex cycles and ASML orderbook fulfillment).

Trade implications: favor concentrated exposure to NVDA (short-dated call spreads) and ASML (12–18 month longs) while shorting DAT vehicles where market price < reported crypto NAV by >10% or using put spreads on MSTR/GBTC-sized to 1–2% portfolio. Hedge macro tail risk with 1-month SPX 5% OTM put spreads sized to protect 0.5–1% portfolio value if Dec 10 outcome diverges from consensus.

Contrarian angles: consensus Fed-cut pricing is a crowded trade — if no cut, cyclicals and financials should outperform for 2–6 weeks; consider modest long exposure to regional banks/bank ETFs on a failed-cut shock and trim tech exposure if NVDA rallies >30% in 30 days (momentum overheat). Also watch Mistral adoption risk: open models may accelerate GPU demand but could compress long-term SaaS margins — cap position sizes and use option structures to keep convexity limited.

Key Decisions for Investors

• Establish a 2–3% portfolio position in NVDA via a 3-month call spread (buy ATM call, sell 10–15% OTM) to capture ~20–30% upside with capped cost; target +25% in 3 months, stop-loss at -12% from entry.
• Buy ASML shares or 12–18 month LEAPs for 1–2% portfolio exposure to secular lithography demand; use a trailing stop or reduce size if orderbook/lead times do not show 10% QoQ improvement within 6 months.
• Initiate a short/hedge on DAT vehicles (e.g., MSTR, GBTC) via 3-month put spreads sized to 1–2% portfolio if market price trades >10% below disclosed crypto NAV or if BTC drops another 15% from current levels.
• Purchase SPX 1-month 5% OTM put spreads (or VIX call package) sized to protect 0.5–1% of portfolio ahead of the Dec 10 FOMC; unwind if Fed cuts 25bp as priced or if realized vol collapses below 12%
• As a contrarian tactical trade, allocate 0.5–1% portfolio to long regional bank ETFs (e.g., KRE) on a failed-cut scenario within 48 hours of the Fed decision, and trim if the trade gaps >12% intraday.